Technical Analysis for BDX - Becton, Dickinson and Company

Grade Last Price % Change Price Change
B 257.13 -0.39% -1.01
BDX closed down 0.39 percent on Thursday, April 22, 2021, on 73 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 5
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical BDX trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Overbought Stochastic Strength 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.39%
Pocket Pivot Bullish Swing Setup -0.39%
Upper Bollinger Band Walk Strength -0.39%
Inside Day Range Contraction -0.39%
Overbought Stochastic Strength -0.39%
Upper Bollinger Band Walk Strength 0.27%
Older End-of-Day Signals for BDX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Becton, Dickinson and Company Description

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. This segment's products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles used in treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices. Its BD Diagnostics segment provides products for the collection and transport of diagnostics specimens; and instrument systems and reagents to detect various infectious diseases, healthcare-associated infections, and cancers. This segment's products comprise integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems; rapid diagnostic assays; microbiology laboratory automation; and plated media. The company's BD Biosciences segment offers research and clinical tools that facilitate the study of cells and their components. This segment's products include fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; laboratory products for tissue culture and fluid handling; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.


Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Biotechnology Biology Pharmaceutical Industry Infectious Diseases Diabetes Antibodies Cancers Monoclonal Antibodies Medical Technology Catheter Franklin Medical Devices Drug Delivery Catheters Medical Tests Microbiology Anesthesia Syringe Laboratory Products Healthcare Associated Infections Treatment Of Diabetes Drug Delivery System Drug Delivery Systems Flow Cytometry Healthcare Institutions Sharps Cell Culture Clinical Tools Becton Becton Dickinson Culture Media Franklin Lakes Healthcare Setting Pharmaceutical Manufacturing Reagent Systems Transfer Devices

Is BDX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 284.97
52 Week Low 219.5
Average Volume 1,191,896
200-Day Moving Average 247.28
50-Day Moving Average 246.79
20-Day Moving Average 249.29
10-Day Moving Average 254.53
Average True Range 4.06
ADX 29.32
+DI 28.50
-DI 12.32
Chandelier Exit (Long, 3 ATRs ) 249.82
Chandelier Exit (Short, 3 ATRs ) 250.78
Upper Bollinger Band 261.96
Lower Bollinger Band 236.62
Percent B (%b) 0.81
BandWidth 10.16
MACD Line 3.68
MACD Signal Line 2.40
MACD Histogram 1.2849
Fundamentals Value
Market Cap 74.53 Billion
Num Shares 290 Million
EPS 2.71
Price-to-Earnings (P/E) Ratio 94.88
Price-to-Sales 3.94
Price-to-Book 2.91
PEG Ratio 2.65
Dividend 3.32
Dividend Yield 1.29%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 260.72
Resistance 3 (R3) 260.77 259.62 260.12
Resistance 2 (R2) 259.62 258.71 259.60 259.92
Resistance 1 (R1) 258.38 258.15 259.00 258.33 259.72
Pivot Point 257.23 257.23 257.55 257.21 257.23
Support 1 (S1) 255.99 256.32 256.61 255.94 254.54
Support 2 (S2) 254.84 255.76 254.82 254.34
Support 3 (S3) 253.60 254.84 254.14
Support 4 (S4) 253.55